Woodline Partners’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Woodline Partners's BIIB Position: Q2 2026 in Review
Woodline Partners increased its Biogen (BIIB) stake by 3.1% in Q2 2026, buying an estimated $656K and bringing the position to 112,463 shares worth $24.3M. The position accounts for 0.08% of the portfolio, ranked #323.
Woodline Partners first reported a position in BIIB in Q1 2021 and has held it in 21 quarters since. The position peaked at $39.8M in Q1 2023. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Woodline Partners held 112,463 shares of Biogen worth $24.3M as of Q2 2026.
- Woodline Partners bought 3,431 Biogen shares in Q2 2026, an estimated $656K.
- Biogen made up 0.08% of Woodline Partners's portfolio in Q2 2026, its #323 holding.
- Woodline Partners first reported a position in Biogen in Q1 2021 and has held it in 21 quarters since.
- Woodline Partners's Biogen position peaked at $39.8M in Q1 2023.
- 1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Woodline Partners's 13F filing for Q2 2026, filed 14 Aug 2026.